Possibilities of dry eye syndrome therapy in various types of ametropia

Purpose : to evaluate the impact of Optinol treatment on ocular surface state in medical students with various types ametropia. Material and methods . The study involved 3 groups patients: two clinical a control group. first group consisted 34 (68 eyes) mild, moderate or high hyperopia, averagely aged 20.1 ± 0.5 years. second 47 (94 myopia, average 20.6 0.9 was composed 60 (120 eyes), 21.4 1.2 years, no ophthalmic pathologies. Each received consecutively three different formulations: Optinol® Gentle Repair: dexpanthenol 2 % sodium hyaluronate 0.15 %, Deep Hydration: 0.4 Express Moisturizer: 0.21 %. case histories patients typical complaints were revealed by questionnaire method. eyelids conjunctiva assessed biomicroscopy. To diagnose dry eye syndrome (DES), special tests used: LIPKOF, Schirmer Norn tests. Results Despite higher LIPKOF scores 1st (hyperopic) group, showing stage III as compared 2nd (myopic) where it scored I, test score showed stronger reduction improved hyperopic falling 1.23 0.10 mm (stage I), which corresponded one conjunctival fold. index tear film stability (Norn's test) increased 1 3.1 0.1 sec, 2.2 0.2 sec. Conclusion DES found be more frequent students. is pathogenetically oriented drug, targeting production disorders changes. drug demonstrates efficacy, good tolerability safety profile, so that could recommended for managing multiple